Federal Register: FDA Issues Proposed Rule on Distributed and Foreign Drug Registration
July 11, 2026
July 11, 2026
WASHINGTON, July 11 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is proposing to amend the drug establishment registration and drug listing requirements with respect to establishments engaged in distributed manufacturing and foreign drug establishments. This action, if finalized, will provide a pathway for a distributed manufactur . . .
* * *
The Food and Drug Administration (FDA) is proposing to amend the drug establishment registration and drug listing requirements with respect to establishments engaged in distributed manufacturing and foreign drug establishments. This action, if finalized, will provide a pathway for a distributed manufactur . . .